F. Morvan
- Oncology top 0.5%
- Cancer Treatment and Pharmacology 18
- Hepatology top 0.5%
- Molecular Biology top 2%
- DNA and Nucleic Acid Chemistry 92
- Advanced biosensing and bioanalysis techniques 83
- RNA Interference and Gene Delivery 51
- Glycosylation and Glycoproteins Research 28
- Organic Chemistry top 2%
- Click Chemistry and Applications 22
- Carbohydrate Chemistry and Synthesis 20
-
- Monoclonal and Polyclonal Antibodies Research 19
- Co-authors
- Jean‐Jacques VasseurChristophe LouvetAimery de GramontAlbert MeyerJean‐Louis ImbachBernard RaynerD. PapamichaelM. Homerin
- Cited by
- OncologyHepatologyMolecular Biology
- Journals
- European Journal of Organic Chemistry (13 papers)Journal of Clinical Oncology (12 papers)Nucleosides Nucleotides & Nucleic Acids (12 papers)
- Partner nations
- FranceItalyUnited States
In The Last Decade
F. Morvan
189 papers receiving 8.0k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Oncology 4.2k
- Hepatology 1.2k
- Molecular Biology 3.6k
- Organic Chemistry 1.2k
- Pulmonary and Respiratory Medicine 1.3k
Countries citing papers authored by F. Morvan
This map shows the geographic impact of F. Morvan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Morvan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Morvan more than expected).
Fields of papers citing papers by F. Morvan
This network shows the impact of papers produced by F. Morvan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Morvan. The network helps show where F. Morvan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside F. Morvan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 2 | |
| 2 | 2019 | 1 | |
| 3 | 2018 | 19 | |
| 4 | 2018 | 4 | |
| 5 | 2017 | 8 | |
| 6 | 2011 | 5 | |
| 7 | 2006 | 33 | |
| 8 | 2004 | 73 | |
| 9 | 2002 | 9 | |
| 10 | 2001 | 1 | |
| 11 | Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancerbreakdown → | 2000 | 3040 |
| 12 | 1997 | 12 | |
| 13 | 1996 | 129 | |
| 14 | 1994 | 28 | |
| 15 | 1993 | 95 | |
| 16 | 1993 | 4 | |
| 17 | Phase II study of tetrahydropyranyl adriamycin (pirarubicin) in elderly patients with advanced breast cancer. | 1992 | 6 |
| 18 | 1992 | 9 | |
| 19 | 1988 | 25 | |
| 20 | 1987 | 102 |
About F. Morvan
F. Morvan is a scholar working on Molecular Biology, Organic Chemistry and Oncology, having authored 194 papers that have together received 8.3k indexed citations. Recurring topics across this work include DNA and Nucleic Acid Chemistry (92 papers), Advanced biosensing and bioanalysis techniques (83 papers), RNA Interference and Gene Delivery (51 papers), Glycosylation and Glycoproteins Research (28 papers), Click Chemistry and Applications (22 papers), Carbohydrate Chemistry and Synthesis (20 papers), Monoclonal and Polyclonal Antibodies Research (19 papers) and Cancer Treatment and Pharmacology (18 papers). The work is most often cited by research in Oncology (4.2k citations), Hepatology (1.2k citations) and Molecular Biology (3.6k citations). F. Morvan has collaborated with scholars based in France, Italy and United States. Frequent co-authors include Jean‐Jacques Vasseur, Christophe Louvet, Aimery de Gramont, Albert Meyer, Jean‐Louis Imbach, Bernard Rayner, D. Papamichael, M. Homerin, H. Cortés-Funes and C. Boni. Their work appears in journals such as European Journal of Organic Chemistry, Journal of Clinical Oncology, Nucleosides Nucleotides & Nucleic Acids, The Journal of Organic Chemistry and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.